Translate page

iCMLf conversation COVID 19 vaccines and CMLThe iCMLf has recently hosted an expert talk on COVID-19 vaccines and CML:

  • Professor Steve Wesselingh, an Infectious Disease physician and researcher in Neurobiology, HIV and vaccine development will provide an overview of the different types of COVID-19 vaccines currently in use around the world.

  • As a haematologist, Dr Kendra Sweet will then put this into perspective for CML.
    She will share current experience with COVID-19 vaccines in patients with CML and provide guidance on how to best manage patients with CML.

 

 
    Collage Wesseling Sweet 2 

 

 

 

Program:
COVID-19 vaccines overview: (Steve Wesselingh)

  • Overview of COVID-19 vaccines
  • Vaccine safety
  • Vaccine effectiveness
  • Vaccine variants
  • Vaccine persistence
  • Vaccines and immunocompromised people
  • Open questions

COVID-19 vaccines for patients with CML (Kendra Sweet)

  • Experience with CML patients infected by COVID-19
  • COVID-19 vaccines assessibility for patients with CML
  • Experience with COVID-19 vaccines in patients with CML
  • Recommendations for patients with CML related to COVID-19 vaccines
  • Patients' perspectives on COVID-19 vaccines

Q&A Session                                                                                                         

Panel of experts:

  • Professor Steve Wesselingh
    South Australia Health and Medical Research Institute, Adelaide (Australia)
  • Dr Kendra Sweet
    Haematologist at the MOFFITT Cancer Center and Research Institute, Tampa (USA)